750 mg PF-04991532: Clinical Trials

1 trial of 750 mg PF-04991532, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow 750 mg PF-04991532: new trials by email Literature Review of 750 mg PF-04991532 trials Research Report on 750 mg PF-04991532

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus
Placebo, 150 mg PF-04991532, 450 mg PF-04991532 - Diabetes, Type 2
Phase 2CompletedPfizer2662011-06-012013-08-06

Conditions studied

Diabetes Mellitus, Type 2 (1)

Sponsors

Pfizer (1)

Countries

Canada (1)  ·  Hungary (1)  ·  Mexico (1)  ·  Slovakia (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  United States (1)